Related Experiment Videos

Chronic immune thrombocytopenia in children: epidemiology and clinical presentation

Carolyn M Bennett1, Michael Tarantino

  • 1Aflac Cancer Center and Blood Disorders Service, Emory University School of Medicine and Children's Healthcare of Atlanta, 5455 Meridian Mark Road, Suite 400, Atlanta, GA 30342, USA. carolyn.bennett@choa.org

Hematology/Oncology Clinics of North America
|November 26, 2009
PubMed

Insights

Immune thrombocytopenic purpura (ITP) in children often resolves spontaneously. However, managing chronic ITP with severe symptoms remains challenging due to limited effective treatments and significant side effects.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Bleeding Disorders

Background:

  • Immune thrombocytopenic purpura (ITP) is a common acquired bleeding disorder in children.
  • Most pediatric cases are acute and self-limiting.
  • A subset develops chronic, clinically significant disease requiring intervention.

Purpose of the Study:

  • To focus on the management strategies for children with clinically significant chronic ITP.
  • To address the challenges in treating severe thrombocytopenia and bleeding in pediatric ITP.
  • To review current therapeutic options and their limitations.

Main Methods:

  • Review of existing literature on pediatric chronic ITP management.
  • Analysis of treatment efficacy and side effect profiles.
  • Focus on interventions for severe thrombocytopenia and bleeding.

Main Results:

  • Chronic ITP management in children presents ongoing clinical challenges.
  • Few available therapies provide long-term remission for severe pediatric ITP.
  • All treatments carry significant side effects and toxicities.

Conclusions:

  • Effective long-term management of severe chronic pediatric ITP is difficult.
  • Further research is needed for safer and more effective therapies.
  • Careful consideration of risks and benefits is crucial for treatment selection.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...